China Specific Cancer Immunotherapy Drugs Market Research Report 2017

January 2017 | 97 pages | ID: CD6B5CC995DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Specific Cancer Immunotherapy Drugs

Revenue, means the sales value of Specific Cancer Immunotherapy Drugs

This report studies Specific Cancer Immunotherapy Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Amgen
• Roche
• Bristol Myers Squibb
• Dendreon (Valeant)
• Novartis
• Seattle Genetics
• Hangzhou Jinjiang Group

Market Segment by Regions (provinces), covering

• South China
• East China
• Southwest China
• Northeast China
• North China
• Central China
• Northwest China

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Tablet
• Injection

Split by Application, this report focuses on consumption, market share and growth rate of Specific Cancer Immunotherapy Drugs in each application, can be divided into

• Leukemia Treatment
• Colorectal Cancer Treatment
• Other Cancer Treatment

Contents

China Specific Cancer Immunotherapy Drugs Market Research Report 2017

1 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Specific Cancer Immunotherapy Drugs Segment by Type
  1.2.1 China Production Market Share of Specific Cancer Immunotherapy Drugs Type in 2015
  1.2.2 Tablet
  1.2.3 Injection
1.3 Applications of Specific Cancer Immunotherapy Drugs
  1.3.1 Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
  1.3.2 Leukemia Treatment
  1.3.3 Colorectal Cancer Treatment
  1.3.4 Other Cancer Treatment
1.4 China Market Size (Value) of Specific Cancer Immunotherapy Drugs (2011-2021)
1.5 China Specific Cancer Immunotherapy Drugs Status and Outlook
1.6 Government Policies

2 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 China Specific Cancer Immunotherapy Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Specific Cancer Immunotherapy Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Specific Cancer Immunotherapy Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Specific Cancer Immunotherapy Drugs Market Competitive Situation and Trends
  2.5.1 Specific Cancer Immunotherapy Drugs Market Concentration Rate
  2.5.2 Specific Cancer Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers

3 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURERS PROFILES/ANALYSIS

3.1 Amgen
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.1.2.1 Tablet
    3.1.2.2 Injection
  3.1.3 Amgen Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Roche
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.2.2.1 Tablet
    3.2.2.2 Injection
  3.2.3 Roche 97 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Bristol Myers Squibb
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.3.2.1 Tablet
    3.3.2.2 Injection
  3.3.3 Bristol Myers Squibb 110 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 Dendreon (Valeant)
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.4.2.1 Tablet
    3.4.2.2 Injection
  3.4.3 Dendreon (Valeant) Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 Novartis
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.5.2.1 Tablet
    3.5.2.2 Injection
  3.5.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Seattle Genetics
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.6.2.1 Tablet
    3.6.2.2 Injection
  3.6.3 Seattle Genetics Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Hangzhou Jinjiang Group
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    3.7.2.1 Tablet
    3.7.2.2 Injection
  3.7.3 Hangzhou Jinjiang Group Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview

4 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Specific Cancer Immunotherapy Drugs Capacity, Production and Growth (2011-2016)
4.2 China Specific Cancer Immunotherapy Drugs Revenue and Growth (2011-2016)
4.3 China Specific Cancer Immunotherapy Drugs Production, Consumption, Export and Import (2011-2016)

5 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Specific Cancer Immunotherapy Drugs Production and Market Share by Type (2011-2016)
5.2 China Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Specific Cancer Immunotherapy Drugs Price by Type (2011-2016)
5.4 China Specific Cancer Immunotherapy Drugs Production Growth by Type (2011-2016)

6 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Specific Cancer Immunotherapy Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 CHINASPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET ANALYSIS BY REGIONS (PROVINCES)

7.1 China Specific Cancer Immunotherapy Drugs Production, Production Value and Price by Regions (Provinces)(2011-2016)
  7.1.1 China Specific Cancer Immunotherapy Drugs Production and Market Share by Regions (Provinces)(2011-2016)
  7.1.2 China Specific Cancer Immunotherapy Drugs Production Value and Market Share by Regions (Provinces)(2011-2016)
  7.1.3 China Specific Cancer Immunotherapy Drugs Sales Price by Regions (Provinces)(2011-2016)
7.2 China Specific Cancer Immunotherapy Drugs Consumption by Regions (Provinces)(2011-2016)
7.3 China Specific Cancer Immunotherapy Drugs Production, Consumption, Export and Import (2011-2016)

8 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURING COST ANALYSIS

8.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 CHINA SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET FORECAST (2016-2021)

12.1 China Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 China Specific Cancer Immunotherapy Drugs Production, Import, Export and Consumption Forecast (2016-2021)
12.3 China Specific Cancer Immunotherapy Drugs Production Forecast by Type (2016-2021)
12.4 China Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2016-2021)
12.5 China Specific Cancer Immunotherapy Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
  12.5.1 China Specific Cancer Immunotherapy Drugs Production Forecast by Regions (Provinces)(2016-2021)
  12.5.2 China Specific Cancer Immunotherapy Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
  12.5.3 China Specific Cancer Immunotherapy Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)
12.6 Specific Cancer Immunotherapy Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Specific Cancer Immunotherapy Drugs
Figure China Production Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015
Figure Product Picture of Tablet
Table Major Manufacturers of Tablet
Figure Product Picture of Injection
Table Major Manufacturers of Injection
Table Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Specific Cancer Immunotherapy Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2015
Figure China Specific Cancer Immunotherapy Drugs Capacity of Key Manufacturers in 2016
Table China Specific Cancer Immunotherapy Drugs Production of Key Manufacturers (2015 and 2016)
Table China Specific Cancer Immunotherapy Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers
Figure 2016 Specific Cancer Immunotherapy Drugs Production Share by Manufacturers
Table China Specific Cancer Immunotherapy Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 China Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table China Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Specific Cancer Immunotherapy Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Specific Cancer Immunotherapy Drugs Product Type
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 3 Manufacturers
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 5 Manufacturers
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Seattle Genetics Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Table Hangzhou Jinjiang Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Market Share (2011-2016)
Figure China Specific Cancer Immunotherapy Drugs Capacity, Production and Growth (2011-2016)
Figure China Specific Cancer Immunotherapy Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production, Consumption, Export and Import (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production by Type (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Specific Cancer Immunotherapy Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Specific Cancer Immunotherapy Drugs by Type
Table China Specific Cancer Immunotherapy Drugs Revenue by Type (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Specific Cancer Immunotherapy Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Specific Cancer Immunotherapy Drugs by Type
Table China Specific Cancer Immunotherapy Drugs Price by Type (2011-2016)
Figure China Specific Cancer Immunotherapy Drugs Production Growth by Type (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Consumption by Application (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Consumption Market Share by Application (2011-2016)
Figure China Specific Cancer Immunotherapy Drugs Consumption Market Share by Application in 2015
Table China Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Specific Cancer Immunotherapy Drugs Consumption Growth Rate by Application (2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production Market Share by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production Value by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production Value Market Share by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Sales Price by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Consumption by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Consumption Market Share by Regions (Provinces)(2011-2016)
Table China Specific Cancer Immunotherapy Drugs Production, Consumption, Export and Import (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure China Specific Cancer Immunotherapy Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Specific Cancer Immunotherapy Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Specific Cancer Immunotherapy Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Specific Cancer Immunotherapy Drugs Production Forecast by Type (2016-2021)
Table China Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2016-2021)
Table China Specific Cancer Immunotherapy Drugs Production Forecast by Regions (Provinces)(2016-2021)
Table China Specific Cancer Immunotherapy Drugs Consumption Forecast by Regions (Provinces)(2016-2021)
Table China Specific Cancer Immunotherapy Drugs Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)